Medically Assisted Reproduction Units and Egg Banks conduct thorough clinical and laboratory evaluations of potential donors, in compliance with Greek legislation and the National Authority for Medically Assisted Reproduction guidelines. Required examinations include:
- Blood group and rhesus factor
- Anti-Müllerian Hormone (AMH) levels
- Blood karyotype analysis
- Cystic fibrosis (CF) screening (99%)
- CF deletions and duplications (MLPA) of the CFTR gene
- Spinal Muscular Atrophy (SMA) screening
- Fragile X syndrome screening
- 35delG mutation in the connexin 26 gene
- Thalassemia (α, β, δβ)
- Sickle cell test
- Ferritin and Iron (Fe) levels
- Hemoglobin electrophoresis (HbA2)
- HIV I, II, anti-HCV, HBsAg, and VDRL tests (within 6 months prior to oocyte retrieval)
- FSH, LH, E2, Progesterone, Prolactin
- TSH, Ft4
- PT, APTT, INR (within 6 months prior to oocyte retrieval)
- Full blood count
Additional Screenings:
- EKG (annually)
- Vaginal culture
- Pap test (annually)
- Glucose, urea, creatinine, AST, ALT
- Transvaginal gynecological scan
- Rapid COVID-19 test (24-48 hours before triggering)
- Psychological evaluation
Personal and Family History:
- Donors complete a detailed personal and family history.
- Donors fill out a genetic disease questionnaire.
After screening, the matching process begins to select a suitable donor based on phenotypic characteristics and blood groups of the recipient couple. Despite the demand, the limited number of willing donors can lead to a waiting period of up to three months for treatment to start.
T: +30 2310 424294